| Dr Suresh K Chirumamilla, MD | |
|
2005 W Park Dr Ste 200, Irving, TX 75061-2034 | |
| (214) 358-2300 | |
| (214) 579-6984 |
| Full Name | Dr Suresh K Chirumamilla |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 18 Years |
| Location | 2005 W Park Dr Ste 200, Irving, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528343241 | NPI | - | NPPES |
| T4727 | Other | TX | TX LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | T4727 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Medical Care Irving | Irving, TX | Dialysis facility |
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Baylor Scott & White Medical Center At Irving | Irving, TX | Hospital |
| Medical City Las Colinas | Irving, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dallas Nephrology Associates | 3870403819 | 128 |
News Archive
Among older adults taking a calcium-channel blocker, simultaneous use of the antibiotic clarithromycin, compared with azithromycin, was associated with a small but statistically significant greater 30-day risk of hospitalization with acute kidney injury, according to a study published by JAMA. The study is being published early online to coincide with its presentation at the American Society of Nephrology's Kidney Week 2013.
Mayo Clinic is teaming up with Phoenix Children's Hospital (PCH) and Pediatric Surgeons of Phoenix to provide comprehensive surgical treatment to both children and adults with pectus deformities.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Critically ill patients who are exposed to higher daily levels of ozone are more likely to develop acute respiratory disease syndrome (ARDS), according to a new study published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 9 days ago
| Entity Name | Dallas Nephrology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861440109 PECOS PAC ID: 3870403819 Enrollment ID: O20040624000638 |
News Archive
Among older adults taking a calcium-channel blocker, simultaneous use of the antibiotic clarithromycin, compared with azithromycin, was associated with a small but statistically significant greater 30-day risk of hospitalization with acute kidney injury, according to a study published by JAMA. The study is being published early online to coincide with its presentation at the American Society of Nephrology's Kidney Week 2013.
Mayo Clinic is teaming up with Phoenix Children's Hospital (PCH) and Pediatric Surgeons of Phoenix to provide comprehensive surgical treatment to both children and adults with pectus deformities.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Critically ill patients who are exposed to higher daily levels of ozone are more likely to develop acute respiratory disease syndrome (ARDS), according to a new study published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suresh K Chirumamilla, MD 1505 Lbj Fwy Ste 700, Dallas, TX 75234-6065 Ph: (214) 358-2300 | Dr Suresh K Chirumamilla, MD 2005 W Park Dr Ste 200, Irving, TX 75061-2034 Ph: (214) 358-2300 |
News Archive
Among older adults taking a calcium-channel blocker, simultaneous use of the antibiotic clarithromycin, compared with azithromycin, was associated with a small but statistically significant greater 30-day risk of hospitalization with acute kidney injury, according to a study published by JAMA. The study is being published early online to coincide with its presentation at the American Society of Nephrology's Kidney Week 2013.
Mayo Clinic is teaming up with Phoenix Children's Hospital (PCH) and Pediatric Surgeons of Phoenix to provide comprehensive surgical treatment to both children and adults with pectus deformities.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
Critically ill patients who are exposed to higher daily levels of ozone are more likely to develop acute respiratory disease syndrome (ARDS), according to a new study published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 9 days ago
Dr. Padmavathy Uppalapati, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, Suite 105, Irving, TX 75038 Phone: 972-607-2525 Fax: 972-252-8837 | |
Rupal Chiniwala, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 6750 N Macarthur Blvd, Suite 150, Irving, TX 75039 Phone: 972-373-0303 Fax: 972-373-8074 | |
Dr. Harikrishna Raja, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 440 W Lyndon B Johnson Fwy Ste 405, Irving, TX 75063 Phone: 972-993-5080 Fax: 972-993-5081 | |
Dr. Deepika Alavala Reddy, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1901 N Macarthur Blvd, Irving, TX 75061 Phone: 972-579-8100 Fax: 972-579-3972 | |
Mrs. Devyani V Deshpande, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7200 N State Hwy 161, Suite 220, Irving, TX 75039 Phone: 214-689-7806 Fax: 214-689-5970 | |
Dr. Sarju Waghela, D.O Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2001 N Macarthur Blvd, #630, Irving, TX 75061 Phone: 972-256-3537 Fax: 972-255-7916 | |
Nauman Siddiqi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, # 105, Irving, TX 75038 Phone: 972-607-2525 |